PROGRAM SCHEDULE
The program is organized in eight sessions that are chaired by speakers who are leaders in their respective fields. Each session includes talks by speakers that are 25 minute talk plus 5 minutes questions (L) or 15min talk plus 5min questions (M), and short oral presentations that are 10 minute talk plus 2 minutes questions (S). Short oral presentations are selected from submitted abstracts. Posters are viewed for the duration of the conference.
To download the program schedule please click here
| May 29 Wednesday | Day 1 | Arrival | |
| 15:00-18:00 | Registration | ||
| 19:00 | Welcome Dinner | ||
| May 30 Thursday | Day 2 | ||
| 7:00-8:15 | Breakfast | ||
| 8:30-11:06 | Session 1: Discovering and Translating Human T cell Immunity | ||
| 8:30-9:20 | L1-Openning Plenary | Mark Davis, Stanford University, USA | Tools for T cells: Specificity and function in autoimmunity, infectious diseases and cancer |
| 9:20-9:50 | L2 | Rene van Lier, Sanquin, The Netherlands | T cell Immunity at the tissue border |
| 9:50-10:10 | M1 | Rama Amara Rao, Emory University, USA | PD-1 Blockade Combined with Therapeutic Vaccination for Functional Cure Against HIV/AIDS |
| 10:10-10:30 | M2 | Amit Awasthi, Translational Health Science and Technology Institute, India | EGFR-HIF1a signalling axis positively regulates the development of Th9 cells |
| 10:30-11:06 | S1 | Short Talk (10min) | |
| S2 | Short Talk (10min) | ||
| S3 | Short Talk (10min) | ||
| 11:06-11:30 | Coffee break & Poster viewing | ||
| 11:30-13:45 | Session 2: Discovering and Translating Human T cell Immunity | ||
| 11:30-12:00 | L3 | Federica Sallusto, Università della Svizzera Italiana, Switzerland | Human Memory T Cell Subsets: From Phenotype To Function |
| 12:00-12:30 | L4 | Peter Katsikis, Erasmus University Medical Center, The Netherlands | miRNA as regulators of CTL immunity |
| 12:30-13:45 | S4 | Short Talk (10min) | |
| S5 | Short Talk (10min) | ||
| S6 | Short Talk (10min) | ||
| S7 | Short Talk (10min) | ||
| S8 | Short Talk (10min) | ||
| S9 | Short Talk (10min) | ||
| 13:45 | Lunch | ||
| 19:00 | Dinner | ||
| May 31 Friday | Day 3 | ||
| 7:00-8:15 | Breakfast | ||
| 8:30-11:05 | Session 3: Understanding and Translating Human B cell responses | ||
| 8:30-9:00 | L5 | Antonio Lanzavecchia, Università della Svizzera Italiana, Switzerland | TBA |
| 9:00-9:30 | L6 | Xiao-Ning Xu, Imperial College London, UK | Dissection of antibody responses to emerging infections in humans by yeast display |
| 9:30-10:00 | L7 | Rene Toes, Leiden University Medical Center, The Netherlands | Take the bitter with the sweet; on the role of variable domain glycans and the breach of tolerance of auto-reactive B-cells in Rheumatoid Arthritis |
| 10:00-10:20 | M3 | Joshy Jacob, Emory University, USA | Templated mutagenesis and the origin of B cell somatic mutants |
| 10:20-10:40 | M4 | Michelle Linterman, Babraham Institute, UK | The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCR clonotypes |
| 10:40-11:05 | S10 | Short Talk (10min) | |
| S11 | Short Talk (10min) | ||
| 11:05-11:30 | Coffee break & Poster viewing | ||
| 11:30-13:50 | Session 4: Systems Immunology of Infections | ||
| 11:30-12:00 | L8 | Yueh-hsiu Chien, Stanford University, USA | Systems analysis of the immune state of Mtb infection |
| 12:00-12:30 | L9 | Tom Ottenhoff, Leiden University Medical Center, The Netherlands | Non-classical innate and adaptive immunity in host defence against Mycobacterium tuberculosis in humans |
| 12:30-13:00 | L10 | Anne O’Garra, The Francis Crick Institute, UK | Cytokine interference in immunity to infection |
| 13:00-13:50 | S12 | Short Talk (10min) | |
| S13 | Short Talk (10min) | ||
| S14 | Short Talk (10min) | ||
| S15 | Short Talk (10min) | ||
| 13:50 | Lunch | ||
| 19:00 | Dinner | ||
| June 1 Saturday | Day 4 | ||
| 7:00-8:15 | Breakfast | ||
| 8:30-11:05 | Session 5: Tumor Immunotherapy | ||
| 8:30-9:00 | L11 | Ugur Sahin, BioNTech, Germany | BioNTech Pharmaceuticals: RNA-based vaccine approaches |
| 9:00-9:30 | L12 | Stephen Schoenberger, La Jolla Institute for Allergy & Immunology, USA | Functional identification of tumor NeoAg |
| 9:30-10:00 | L13 | Özlem Türeci, BioNTech, Germany | Cluster for Individualized ImmunoIntervention (CI3): Novel immunotherapies based on targeting Claudin family members |
| 10:00-10:20 | M5 | George Pavlakis, National Cancer Institute, USA | Clinical development of heterodimeric IL-15 for cancer immunotherapy |
| 10:20-10:40 | M6 | Enrico Lugli, Humanitas Clinical and Research Center, Italy | High-Dimensional Single-Cell Profiling Identifies an Effector Treg Molecular Program Governing Human Lung Cancer Disease Progression |
| 10:40-11:05 | S16 | Short Talk (10min) | |
| S17 | Short Talk (10min) | ||
| 11:05-11:30 | Coffee break & Poster viewing | ||
| 11:30-13:40 | Session 6: Systems Immunology and Vaccines | ||
| 11:30-12:00 | L14 | Bali Pulendran, Stanford University, USA | Systems Immunology of vaccination |
| 12:00-12:30 | L15 | Alison Humbles, MedImmune, USA | Translational relevance of ILCs and plasticity in shaping human Respiratory disease |
| 12:30-13:00 | L16 | Ken Ishii, University of Tokyo, Japan | Nuclear cytokines and extracellular nucleic acids in infection and vaccination |
| 13:00-13:20 | M7 | Ioanna Skountzou, Emory University, USA | TIV immunization with a thermostable microneedle patch-Immunogenicity and Transcriptomics results from a Phase I Clinical Trial |
| 13:20-13:40 | M8 | Petter Brodin, Karolinska Institute, Sweden | Systems-level analysis of immune variation and the influence of environmental exposures early in life |
| 13:40 | Lunch | ||
| 15:30 | Tour | ||
| 19:00 | Dinner | ||
| June 2 Sunday | Day 5 | ||
| 7:00-8:15 | Breakfast | ||
| 8:30-11:00 | Session 7: Discovering and Translating Innate Immunity | ||
| 8:30-9:00 | L17 | Mihai Netea, Radboud University Medical Center, The Netherlands | Trained immunity: epigenetic and metabolic reprogramming of innate host defense |
| 9:00-9:30 | L18 | Adrian Hayday, The Francis Crick Institute, UK | Discriminating normality from dysregulation |
| 9:30-10:00 | L19 | Roxane Tussiwand, University of Basel, Switzerland & NIH, USA | When origin matters: redefining the plasmacytoid dendritic cell subset |
| 10:00-10:20 | M9 | Eynav Klechevsky, Washington University in St. Louis, USA | Upstream regulation of autoimmunity and cancer via human dendritic cell subsets |
| 10:20-10:40 | M10 | Evangelos Andreakos, Biomedical Research Foundation, Academy of Athens, Greece | Lambda interferons constitute dual function cytokines mediating antiviral immunity and damage control |
| 10:40-11:00 | M11 | Dina Alexandropoulos, Icahn School of Medicine at Mount Sinai, USA | Immune Profiling and Target Identification of Human Liver Inflammatory Diseases |
| 11:00-11:30 | Coffee break & Poster viewing | ||
| 11:30-13:50 | Session 8: Translating immunity: From Bedside to Bench and Back | ||
| 11:30-12:20 | S18 | Short Talk (10min) | |
| S19 | Short Talk (10min) | ||
| S20 | Short Talk (10min) | ||
| S21 | Short Talk (10min) | ||
| 12:20-12:50 | L20 | Yong-Jun Liu, Sanofi, France | Translating human immunobiology to medicine |
| 12:50-13:20 | L21 | Helen Su, National Institutes of Health (NIH), USA | Mechanistic insights into human immunity through the study of a novel human immunodeficiency-immunodysregulation disorder |
| 13:20-13:50 | L22 | Rino Rappuoli, GSK Vaccines, Italy | TBA |
| 13:50 | Lunch | ||
| 20:00 | Gala dinner | ||
| June 3 Monday | Day 6 | Departure | |
| 7:00-9:30 | Breakfast |